CALCIUM LIPOSOME BABY - Vietnam Registration 230001931/PCBA-HN
Access comprehensive regulatory information for CALCIUM LIPOSOME BABY in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi A medical device is registered under number 230001931/PCBA-HN and manufactured by MEDYPHARM Central Pharmaceutical Corporation.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
230001931/PCBA-HN
000.00.19.H26-231005-0020
CALCIUM LIPOSOME BABY
Technical Details
Calcium helps children absorb a large amount of calcium in a short period of time, supporting bone and teeth health, which is a crucial step in helping children grow taller. It helps prevent constipation in children, laying the foundation for their growth. It is recommended for children during the growth and development stage, supporting their health and bone strength, and treating and preventing osteoporosis. It helps reduce bone pain and inflammation during movement and speeds up the healing of bone fractures. Calcium has a regulatory effect on heart function, improves memory, and reduces the incidence of night crying in children.
Dates and Status
Oct 06, 2023

